Magnus Financial Group LLC bought a new position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,565 shares of the medical technology company’s stock, valued at approximately $227,000.
A number of other institutional investors have also bought and sold shares of the business. Oregon Public Employees Retirement Fund boosted its holdings in Hill-Rom by 8,755.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 2,281,991 shares during the period. HealthCor Management L.P. bought a new stake in shares of Hill-Rom in the third quarter valued at about $76,253,000. Jennison Associates LLC lifted its stake in shares of Hill-Rom by 47.0% in the third quarter. Jennison Associates LLC now owns 978,335 shares of the medical technology company’s stock valued at $92,355,000 after buying an additional 312,771 shares during the period. Select Equity Group L.P. bought a new stake in shares of Hill-Rom in the third quarter valued at about $28,996,000. Finally, Bank of New York Mellon Corp lifted its stake in shares of Hill-Rom by 27.0% in the fourth quarter. Bank of New York Mellon Corp now owns 1,038,521 shares of the medical technology company’s stock valued at $91,961,000 after buying an additional 220,981 shares during the period. 84.22% of the stock is currently owned by hedge funds and other institutional investors.
HRC has been the subject of several research reports. Zacks Investment Research cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Tuesday, November 27th. UBS Group initiated coverage on shares of Hill-Rom in a research note on Tuesday, November 27th. They issued a “buy” rating and a $115.00 target price for the company. ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a research note on Saturday, January 19th. Morgan Stanley reduced their target price on shares of Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 2nd. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $116.00 target price on shares of Hill-Rom in a research note on Monday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $103.78.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, January 25th. The medical technology company reported $1.02 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.04. The firm had revenue of $683.50 million during the quarter, compared to analysts’ expectations of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.92 earnings per share. As a group, sell-side analysts anticipate that Hill-Rom Holdings, Inc. will post 5.04 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 22nd will be paid a dividend of $0.21 per share. This is a boost from Hill-Rom’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Thursday, March 21st. This represents a $0.84 dividend on an annualized basis and a yield of 0.80%. Hill-Rom’s dividend payout ratio (DPR) is currently 16.84%.
COPYRIGHT VIOLATION WARNING: “Magnus Financial Group LLC Invests $227,000 in Hill-Rom Holdings, Inc. (HRC) Stock” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/4223333/magnus-financial-group-llc-invests-227000-in-hill-rom-holdings-inc-hrc-stock.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
See Also: Why Net Income is Important to Investors
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.